All Stories

  1. Cell cycle activation in p21 dependent pathway: An alternative mechanism of organophosphate induced dopaminergic neurodegeneration
  2. Dynamics of diabetes and obesity: Epidemiological perspective
  3. Is Alzheimer's disease a Type 3 Diabetes? A critical appraisal
  4. Therapeutics of Neurotransmitters in Alzheimer’s Disease
  5. Mitochondria-targeted small molecule SS31: a potential candidate for the treatment of Alzheimer’s disease
  6. Novel 1, 4-dihydropyridines for L-type calcium channel as antagonists for cadmium toxicity
  7. Mitochondria-targeted small molecule SS31: a potential candidate for the treatment of Alzheimer’s disease
  8. A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease
  9. MicroRNAs, Aging, Cellular Senescence, and Alzheimer's Disease
  10. Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer’s disease
  11. Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer’s disease
  12. Protective effects of a natural product, curcumin, against amyloid β induced mitochondrial and synaptic toxicities in Alzheimer's disease
  13. Quercetin attenuates neuronal death against aluminum-induced neurodegeneration in the rat hippocampus
  14. Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesis
  15. Aluminum and Alzheimer's disease
  16. Garrison Institute on Aging: A New Hope for Elderly Individuals and Patients with Alzheimer’s Disease
  17. Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia
  18. Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer
  19. CSF Ubiquitin As a Specific Biomarker in Alzheimer's Disease
  20. Imaging and curcumin delivery in pancreatic cancer cell lines using PEGylated α-Gd2(MoO4)3mesoporous particles
  21. Caspase inhibition augments Dichlorvos-induced dopaminergic neuronal cell death by increasing ROS production and PARP1 activation
  22. Aluminium induced oxidative stress results in decreased mitochondrial biogenesis via modulation of PGC-1α expression
  23. CSF p-Tau levels in the prediction of Alzheimer's disease
  24. PEGylated α-Gd2(MoO4)3Mesoporous Flowers: Synthesis, Characterization, and Biological Application
  25. Apolipoprotein E Levels in the Cerebrospinal Fluid of North Indian Patients With Alzheimer’s Disease
  26. Effect of Resveratrol and Nicotine on PON1 Gene Expression: In Vitro Study
  27. Quercetin Protects Against Chronic Aluminum-Induced Oxidative Stress and Ensuing Biochemical, Cholinergic, and Neurobehavioral Impairments in Rats
  28. siRNA against presenilin 1 (PS1) down regulates amyloid β42 production in IMR-32 cells
  29. Protective efficacy of mitochondrial targeted antioxidant MitoQ against dichlorvos induced oxidative stress and cell death in rat brain
  30. Protective Efficacy of Coenzyme Q10 Against DDVP-Induced Cognitive Impairments and Neurodegeneration in Rats
  31. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population
  32. Cerebrospinal fluid profile of amyloid β42 (Aβ42), hTau and ubiquitin in North Indian Alzheimer's disease patients
  33. Nigrostriatal neuronal death following chronic dichlorvos exposure: crosstalk between mitochondrial impairments, α synuclein aggregation, oxidative damage and behavioral changes
  34. Mitochondrial energy metabolism impairment and liver dysfunction following chronic exposure to dichlorvos